位置:首页 > 蛋白库 > KCNK5_HUMAN
KCNK5_HUMAN
ID   KCNK5_HUMAN             Reviewed;         499 AA.
AC   O95279; B2RAQ6; B5TJL2; Q5VV76;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=Potassium channel subfamily K member 5 {ECO:0000305};
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-2;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 2;
GN   Name=KCNK5 {ECO:0000312|HGNC:HGNC:6280}; Synonyms=TASK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=9812978; DOI=10.1074/jbc.273.47.30863;
RA   Reyes R., Duprat F., Lesage F., Fink M., Salinas M., Farman N.,
RA   Lazdunski M.;
RT   "Cloning and expression of a novel pH-sensitive two pore domain K+ channel
RT   from human kidney.";
RL   J. Biol. Chem. 273:30863-30869(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERCHAIN DISULFIDE BOND.
RX   PubMed=12851074; DOI=10.1080/0968768031000084181;
RA   Niemeyer M.I., Cid L.P., Valenzuela X., Paeile V., Sepulveda F.V.;
RT   "Extracellular conserved cysteine forms an intersubunit disulphide bridge
RT   in the KCNK5 (TASK-2) K+ channel without having an essential effect upon
RT   activity.";
RL   Mol. Membr. Biol. 20:185-191(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
CC   -!- FUNCTION: pH-dependent, outwardly rectifying potassium channel
CC       (PubMed:9812978). Outward rectification is lost at high external K(+)
CC       concentrations (PubMed:9812978). {ECO:0000269|PubMed:9812978}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC   -!- INTERACTION:
CC       O95279; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-3934936, EBI-10827839;
CC       O95279; Q6RW13-2: AGTRAP; NbExp=3; IntAct=EBI-3934936, EBI-11522760;
CC       O95279; P29972: AQP1; NbExp=3; IntAct=EBI-3934936, EBI-745213;
CC       O95279; P18859: ATP5PF; NbExp=3; IntAct=EBI-3934936, EBI-2606700;
CC       O95279; Q12982: BNIP2; NbExp=3; IntAct=EBI-3934936, EBI-752094;
CC       O95279; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-3934936, EBI-11522780;
CC       O95279; P21964: COMT; NbExp=3; IntAct=EBI-3934936, EBI-372265;
CC       O95279; O43169: CYB5B; NbExp=3; IntAct=EBI-3934936, EBI-1058710;
CC       O95279; P29033: GJB2; NbExp=3; IntAct=EBI-3934936, EBI-3905204;
CC       O95279; P24593: IGFBP5; NbExp=3; IntAct=EBI-3934936, EBI-720480;
CC       O95279; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-3934936, EBI-2820517;
CC       O95279; Q9Y2E5: MAN2B2; NbExp=3; IntAct=EBI-3934936, EBI-12243024;
CC       O95279; Q8N138: ORMDL3; NbExp=3; IntAct=EBI-3934936, EBI-721750;
CC       O95279; Q8N2U9: SLC66A2; NbExp=3; IntAct=EBI-3934936, EBI-3907610;
CC       O95279; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-3934936, EBI-8640191;
CC       O95279; P0DN84: STRIT1; NbExp=3; IntAct=EBI-3934936, EBI-12200293;
CC       O95279; P48230: TM4SF4; NbExp=3; IntAct=EBI-3934936, EBI-8650934;
CC       O95279; Q5BJH2-2: TMEM128; NbExp=3; IntAct=EBI-3934936, EBI-10694905;
CC       O95279; Q9Y6G1: TMEM14A; NbExp=3; IntAct=EBI-3934936, EBI-2800360;
CC       O95279; Q96HP8: TMEM176A; NbExp=3; IntAct=EBI-3934936, EBI-2800645;
CC       O95279; A2RU14: TMEM218; NbExp=3; IntAct=EBI-3934936, EBI-10173151;
CC       O95279; Q969K7: TMEM54; NbExp=3; IntAct=EBI-3934936, EBI-3922833;
CC       O95279; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-3934936, EBI-2852148;
CC       O95279; O14798: TNFRSF10C; NbExp=3; IntAct=EBI-3934936, EBI-717441;
CC       O95279; Q86UF1: TSPAN33; NbExp=3; IntAct=EBI-3934936, EBI-12045841;
CC       O95279; Q15836: VAMP3; NbExp=3; IntAct=EBI-3934936, EBI-722343;
CC       O95279; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-3934936, EBI-751210;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Abundant expression in kidney, also detected in
CC       liver, placenta and small intestine. In the kidney, expression is
CC       restricted to the distal tubules and collecting ducts (PubMed:9812978).
CC       Not expressed in proximal tubules or glomeruli (PubMed:9812978).
CC       {ECO:0000269|PubMed:9812978}.
CC   -!- MISCELLANEOUS: Inhibited by quinine, quinidine and external
CC       acidification. {ECO:0000269|PubMed:9812978}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF084830; AAC79458.1; -; mRNA.
DR   EMBL; EU978936; ACH86095.1; -; mRNA.
DR   EMBL; AK314298; BAG36953.1; -; mRNA.
DR   EMBL; AL451185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03979.1; -; Genomic_DNA.
DR   EMBL; BC060793; AAH60793.1; -; mRNA.
DR   EMBL; BC069573; AAH69573.1; -; mRNA.
DR   CCDS; CCDS4841.1; -.
DR   RefSeq; NP_003731.1; NM_003740.3.
DR   AlphaFoldDB; O95279; -.
DR   SMR; O95279; -.
DR   BioGRID; 114197; 31.
DR   IntAct; O95279; 29.
DR   STRING; 9606.ENSP00000352527; -.
DR   BindingDB; O95279; -.
DR   ChEMBL; CHEMBL4523157; -.
DR   GuidetoPHARMACOLOGY; 517; -.
DR   TCDB; 1.A.1.8.2; the voltage-gated ion channel (vic) superfamily.
DR   GlyGen; O95279; 1 site.
DR   iPTMnet; O95279; -.
DR   PhosphoSitePlus; O95279; -.
DR   BioMuta; KCNK5; -.
DR   EPD; O95279; -.
DR   jPOST; O95279; -.
DR   MassIVE; O95279; -.
DR   MaxQB; O95279; -.
DR   PaxDb; O95279; -.
DR   PeptideAtlas; O95279; -.
DR   PRIDE; O95279; -.
DR   ProteomicsDB; 50787; -.
DR   Antibodypedia; 15697; 110 antibodies from 29 providers.
DR   DNASU; 8645; -.
DR   Ensembl; ENST00000359534.4; ENSP00000352527.3; ENSG00000164626.9.
DR   GeneID; 8645; -.
DR   KEGG; hsa:8645; -.
DR   MANE-Select; ENST00000359534.4; ENSP00000352527.3; NM_003740.4; NP_003731.1.
DR   UCSC; uc003oon.4; human.
DR   CTD; 8645; -.
DR   DisGeNET; 8645; -.
DR   GeneCards; KCNK5; -.
DR   HGNC; HGNC:6280; KCNK5.
DR   HPA; ENSG00000164626; Tissue enhanced (intestine, kidney).
DR   MIM; 603493; gene.
DR   neXtProt; NX_O95279; -.
DR   OpenTargets; ENSG00000164626; -.
DR   PharmGKB; PA30062; -.
DR   VEuPathDB; HostDB:ENSG00000164626; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   GeneTree; ENSGT00940000156775; -.
DR   HOGENOM; CLU_040658_0_0_1; -.
DR   InParanoid; O95279; -.
DR   OMA; TEEWNYI; -.
DR   OrthoDB; 1211599at2759; -.
DR   PhylomeDB; O95279; -.
DR   TreeFam; TF313947; -.
DR   PathwayCommons; O95279; -.
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   SignaLink; O95279; -.
DR   BioGRID-ORCS; 8645; 22 hits in 1081 CRISPR screens.
DR   ChiTaRS; KCNK5; human.
DR   GeneWiki; KCNK5; -.
DR   GenomeRNAi; 8645; -.
DR   Pharos; O95279; Tchem.
DR   PRO; PR:O95279; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O95279; protein.
DR   Bgee; ENSG00000164626; Expressed in pancreatic ductal cell and 153 other tissues.
DR   ExpressionAtlas; O95279; baseline and differential.
DR   Genevisible; O95279; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; IDA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; ISS:ARUK-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IDA:GO_Central.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0060075; P:regulation of resting membrane potential; ISS:ARUK-UCL.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003; PTHR11003; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN           1..499
FT                   /note="Potassium channel subfamily K member 5"
FT                   /id="PRO_0000101749"
FT   TOPO_DOM        1..7
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        8..26
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        85..112
FT                   /note="Pore-forming; Name=Pore-forming 1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        113..133
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        134..157
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        158..180
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        190..215
FT                   /note="Pore-forming; Name=Pore-forming 2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..250
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        251..325
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          312..335
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          360..388
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          428..499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        463..499
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   CARBOHYD        77
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        51
FT                   /note="Interchain"
FT   VARIANT         465
FT                   /note="P -> T (in dbSNP:rs9462487)"
FT                   /id="VAR_052425"
FT   CONFLICT        423
FT                   /note="V -> A (in Ref. 3; BAG36953)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   499 AA;  55130 MW;  E871A7A4823DDA00 CRC64;
     MVDRGPLLTS AIIFYLAIGA AIFEVLEEPH WKEAKKNYYT QKLHLLKEFP CLGQEGLDKI
     LEVVSDAAGQ GVAITGNQTF NNWNWPNAMI FAATVITTIG YGNVAPKTPA GRLFCVFYGL
     FGVPLCLTWI SALGKFFGGR AKRLGQFLTK RGVSLRKAQI TCTVIFIVWG VLVHLVIPPF
     VFMVTEGWNY IEGLYYSFIT ISTIGFGDFV AGVNPSANYH ALYRYFVELW IYLGLAWLSL
     FVNWKVSMFV EVHKAIKKRR RRRKESFESS PHSRKALQVK GSTASKDVNI FSFLSKKEET
     YNDLIKQIGK KAMKTSGGGE TGPGPGLGPQ GGGLPALPPS LVPLVVYSKN RVPTLEEVSQ
     TLRSKGHVSR SPDEEAVARA PEDSSPAPEV FMNQLDRISE ECEPWDAQDY HPLIFQDASI
     TFVNTEAGLS DEETSKSSLE DNLAGEESPQ QGAEAKAPLN MGEFPSSSES TFTSTESELS
     VPYEQLMNEY NKANSPKGT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024